Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
Anderson Diagnostics & Labs in Chennai partners with Manipal Academy of Higher Education to launch the MAHE-Anderson Centre of Excellence in Reproductive Genomics. This initiative aims to ...
A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...
How does personalised medicine work across different cancer types? Oncologist Dr Valerie Yang from OncoCare Cancer Centre ...
Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...
Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...
DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...
The global digestive health market is booming, valued at $51bn (€43bn) and projected to reach $68bn by 2030 with an 8.3% CAGR ...
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its next-generation TRK ...
We call him the Evil Genius for a reason. Green helped define the early 2000s — an architect of the mixtape golden age who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback